aTYR PHARMA INC: cashflow_investing

Value{"amount": 11494000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"}
Period2026-01-01 – 2026-03-31
Statuscurrent
EntityaTYR PHARMA INC
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001339970-26-000033 · Open the official SEC filing →
Retrieved: 2026-08-19T12:49:30.486433+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001339970/cashflow-investing/2026-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/eecd965a-1c14-46a2-baf2-9586e9c63f9e

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies